首页> 外文期刊>European radiology >Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors
【24h】

Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors

机译:与Li-Rads V2018以外的肝细胞癌(HCC)以外的原发性肝癌的评估:Li-rads靶人群对没有Li-rads定义的HCC风险因素的患者的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives To determine whether the LI-RADS imaging features of primary liver carcinomas (PLCs) other than hepatocellular carcinoma (non-HCC PLCs) differ between patients considered high risk (RF+) versus not high risk (RF-) for HCC and to compare rates of miscategorization as probable or definite HCC between the RF+ and RF- populations. Methods This retrospective study included all pathology-proven non-HCC PLCs imaged with liver-protocol CT or MRI from 2007 to 2017 at two liver transplant centers. Patients were defined per LI-RADS v2018 criteria as RF+ or RF-. Two independent, blinded readers (R1, R2) categorized 265 lesions using LI-RADS v2018. Logistic regression was utilized to assess for differences in imaging feature frequencies between RF+ and RF- patients. Fisher's exact test was used to assess for differences in miscategorization rates. Results Non-HCC PLCs were significantly more likely to exhibit nonrim arterial phase hyperenhancement (R1: OR = 2.94; R2: OR = 7.09) and nonperipheral "washout" (R1: OR = 3.65; R2: OR = 7.69) but significantly less likely to exhibit peripheral "washout" (R1: OR = 0.30; R2: OR = 0.10) and delayed central enhancement (R1: OR = 0.18; R2: OR = 0.25) in RF+ patients relative to RF- patients. Consequently, non-HCC PLCs were more often miscategorized as probable or definite HCC in RF+ versus RF- patients (R1: 23.3% vs. 3.6%, p < 0.001; R2: 11.0% vs. 2.6%, p = 0.009). Conclusions Non-HCC PLCs are more likely to mimic HCCs on CT and MRI in the LI-RADS target population than in patients without LI-RADS-defined HCC risk factors.
机译:目的是确定除肝细胞癌(非HCC PLC)以外的原发性肝癌(PLC)的LI-RADS成像特征是否与HCC的高风险(RF +)与HCC的高风险(RF +)相反,并比较率在RF +和RF-群之间的错误分类是可能的或明确的HCC。方法本回顾性研究包括在两种肝脏移植中心的2007至2017年与肝协议CT或MRI成像的所有病理证明的非HCC PLC。患者定义为每Li-Rads V2018标准作为RF +或RF-。使用LI-RADS V2018,两个独立的,盲读者(R1,R2)分类为265个病变。物流回归用于评估RF +和RF患者之间的成像特征频率的差异。 Fisher的确切测试用于评估错误分类率的差异。结果非HCC PLC显着表现出非革命性阶段高变性(R1:OR = 2.94; R2:OR = 7.09)和非孔链“冲洗”(R1:或= 3.65; R2:或= 7.69),但显着不太可能为了表现出周围的“冲洗”(R1:或= 0.30; R2:或= 0.10)和RF +患者在RF患者中延迟中央增强(R1:或= 0.18; R2:OR = 0.25)。因此,非HCC PLC更常见于RF +与RF-患者的可能性或明确的HCC(R1:23.3%与3.6%,P <0.001; R2:11.0%与2.6%,P = 0.009)。结论非HCC PLC更有可能在Li-Rads靶人群中对CT和MRI的MCCS模仿HCC,而不是在没有Li-rad-Radi定义的HCC风险因素的患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号